Found: 4
Select item for more details and to access through your institution.
The interval between progression and therapy initiation is the key prognostic parameter in relapsing diffuse large B cell lymphoma: analysis from the Czech Lymphoma Study Group database (NIHIL).
- Published in:
- 2020
- By:
- Publication type:
- journal article
First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 4, p. 669, doi. 10.1007/s00277-017-3218-0
- By:
- Publication type:
- Article
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.60
- By:
- Publication type:
- Article